Pathology Core
$144,461P01FY2013AINIH
Indiana University Indianapolis, Indianapolis IN
Investigators
Linked publications, trials & patents
Paper 33062840Paper 31325493Paper 29884698Paper 29360666Paper 29057202Paper 28734943Paper 27801552Paper 27494303Paper 27363389Paper 26721885Paper 25987251Paper 25773063Paper 25186179Paper 24979671Paper 24930532Paper 24901241Paper 24866539Paper 24265781Paper 24212502Paper 24205828Paper 24204629Paper 24043901Paper 23806772Paper 23665523Paper 23298205Paper 23262228Paper 23262227Paper 23152566Paper 23087052Paper 23060441Paper 22805894Paper 22525701Paper 22433165Paper 21925897Paper 21606603Paper 21521466Paper 20814021
Abstract
Despite improvements in management of acute allograft rejection and 1 year survival of allografts, many organs succumb sooner or later to chronic allograft rejection/injury. Important contributor to this process is chronic vascular rejection in any organ, and bronchilitis obliterans in transplanted lungs. In the present program project we propose that the abnormal deposits of extracellular matrix seen in bronchioles with obliterative bronchiolitis and arteries with chronic allograft vasculopathy obey to an abnormal humoral and cellular immunity to the generation of excess col(V) al homotrimers in the extracellular matrix. The goal of the Core C,
View original record on NIH RePORTER →